Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M …

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously …
See all stories on this topic »